TARGET FIRST, NCT04753749 / 2020-005933-34: Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy |
|
|
| Active, not recruiting | N/A | 2248 | Europe | Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin), Standard DAPT | MicroPort CRM, European Cardiovascular Research Center | Myocardial Infarction, Acute, Coronary Artery Disease | 04/25 | 04/25 | | |
